{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:31:04Z","timestamp":1789180264922,"version":"build-2803163510"},"reference-count":40,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ThoracResPract"],"DOI":"10.4274\/thoracrespract.2024.23076","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:21:10Z","timestamp":1736266870000},"page":"32-39","source":"Crossref","is-referenced-by-count":3,"title":["Non-invasive Mechanical Ventilation in Lung Cancer: Physiological Principles and Clinical Utilization in Surgical and Non-surgical Settings"],"prefix":"10.4274","volume":"26","author":[{"given":"Marco","family":"Cascella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio M.","family":"Esquinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"ref0","unstructured":"1-) Centers for Disease Control and Prevention (CDC). Leishmaniasis. Available from: https:\/\/www.cdc.gov\/leishmaniasis\/about\/index.html (Accessed date: 12.06.2024)"},{"key":"ref1","unstructured":"2-) World Health Organization (WHO). Leishmaniasis. Key facts. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis (Accessed date: 12.06.2024)."},{"key":"ref2","unstructured":"3-) World Health Organization (WHO). Global leishmaniasis surveillance: 2019-2020, a baseline for the 2030 roadmap. Weekly epidemiological record."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4-) Muhjazi G, Gabrielli AF, Ruiz-Postigo JA, Atta H, Osman M, Bashour H, et al. Cutaneous leishmaniasis in Syria: A review of available data during the war years: 2011-2018. PLoS Negl Trop Dis 2019; 13(12): e0007827.","DOI":"10.1371\/journal.pntd.0007827"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5-) Berbert TRN, de Mello TFP, Wolf Nassif P, Mota CA, Silveira AV, Duarte GC, et al. Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review. Dermatol Res Pract 2018; 9014726.","DOI":"10.1155\/2018\/9014726"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"6-) Sundar","year":"2012","unstructured":"6-) Sundar S, Singh A, Rai M, Prajapati VK, Singh AK, Ostyn B, et al. Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis 2012; 55(4): 543-50.","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3389\/fmicb.2018.02990","article-title":"Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance","volume":"9","author":"7-) Shriram","year":"2018","unstructured":"7-) Shriram V, Khare T, Bhagwat R, Shukla R, Kumar V. Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance. Front Microbiol 2018; 9: 2990.","journal-title":"Front Microbiol"},{"issue":"2","key":"ref7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","article-title":"Efflux pump inhibitors for bacterial pathogens: From bench to bedside","volume":"149","author":"8-) Sharma","year":"2019","unstructured":"8-) Sharma A, Gupta VK, Pathania R. Efflux pump inhibitors for bacterial pathogens: From bench to bedside. Indian J Med Res 2019; 149(2): 129.","journal-title":"Indian J Med Res"},{"issue":"12","key":"ref8","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1021\/cr050521a","article-title":"Reserpine: A challenge for total synthesis of natural products","volume":"105","author":"9-) Chen FE","year":"2005","unstructured":"9-) Chen FE, Huang J. Reserpine: A challenge for total synthesis of natural products. Chem Rev 2005; 105(12): 4671-706.","journal-title":"Chem Rev"},{"issue":"18","key":"ref9","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.scib.2020.12.035","article-title":"Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p","volume":"66","author":"10-) Tong","year":"2021","unstructured":"10-) Tong Y, Zhang J, Sun N, Wang XM, Wei Q, Zhang Y, et al. Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p. Sci Bull (Beijing) 2021; 66(18): 1895-905.","journal-title":"Sci Bull (Beijing)"},{"key":"ref10","unstructured":"11-) Pillai SK, Moellering RC, Eliopoulos GM. Antimicrobial combinations, In: Lorian V (eds), Antibiotics in laboratory medicine. Lippincott Williams & Wilkins, Philadelphia. 2005: pp. 365-439."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/1471-2334-13-548","article-title":"Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China","volume":"13","author":"12-) Li Yj","year":"2013","unstructured":"12-) Li Yj, Pan CZ, Zhao ZW, Zhao ZX, Chen HL, Lu WB. Effects of a combination of amlodipine and imipenem on 42 clinical isolates of Acinetobacter baumannii obtained from a teaching hospital in Guangzhou, China. BMC Infect Dis 2013; 13: 548.","journal-title":"BMC Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13-) Ponte-Sucre A, Gamarro F, Dujardin JC, Barret MP, Lopez-Velez R, Garcia-Hernadez R, et al. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl Trop Dis 2017; 11(12): e0006052.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13568-022-01419-5","article-title":"The role of ATP-binding cassette transporter genes expression in treatment failure cutaneous leishmaniasis","volume":"12","author":"14-) Boozhmehrani","year":"2022","unstructured":"14-) Boozhmehrani MJ, Eslami G, Khamesipour A, Jafari AA, Vakili M, Hosseini SS, et al. The role of ATP-binding cassette transporter genes expression in treatment failure cutaneous leishmaniasis. AMB Expr 2022; 12: 78.","journal-title":"AMB Expr"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/biom14040406","article-title":"Unmasking the mechanism behind miltefosine: Revealing the disruption of intracellular Ca2+ homeostasis as a rational therapeutic target in leishmaniasis and chagas disease","volume":"14","author":"15-) Benaim","year":"2024","unstructured":"15-) Benaim G, Paniz-Mondolfi A. Unmasking the mechanism behind miltefosine: Revealing the disruption of intracellular Ca2+ homeostasis as a rational therapeutic target in leishmaniasis and chagas disease. Biomolecules 2024; 14(4): 406.","journal-title":"Biomolecules"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16-) Coelho AC, Cotrim PC. The role of ABC transporters in drug-resistant Leishmania, In Drug resistance in Leishmania parasites. Springer 2018: 247-72.","DOI":"10.1007\/978-3-319-74186-4_11"},{"issue":"11","key":"ref16","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1021\/acsomega.3c09400","article-title":"Genomic insight of leishmania parasite: In-depth review of drug resistance mechanisms and genetic mutations","volume":"9","author":"17-) Bharadava","year":"2024","unstructured":"17-) Bharadava K, Upadhyay TK, Kaushal RS, Ahmad I, Alraey Y, Siddiqui S, et al. Genomic insight of leishmania parasite: In-depth review of drug resistance mechanisms and genetic mutations. ACS Omega 2024; 9(11): 12500-14.","journal-title":"ACS Omega"},{"issue":"2","key":"ref17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.45.2.439-446.2001","article-title":"High affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin","volume":"45","author":"18-) Perez-Victoria","year":"2001","unstructured":"18-) Perez-Victoria JM, Perez-Victoria FJ, Conseil G, Maitrejean M, Comte G, Barron D, et al. High affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin. Antimicrob Agents Chemother 2001; 45(2): 439-46.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1134\/S0026893319040113","article-title":"Reserpine is the new addition into the repertoire of AcrB efflux pump inhibitors","volume":"53","author":"19-) Shaheen","year":"2019","unstructured":"19-) Shaheen A, Afridi WA, Mahboob S, Sana M, Ismat F, Mirza O, et al. Reserpine is the new addition into the repertoire of AcrB efflux pump inhibitors. Mol Biol (Mosk) 2019; 53: 596-605.","journal-title":"Mol Biol (Mosk)"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/02698811221115762","article-title":"The effects of reserpine on depression: A systematic review","volume":"37","author":"20-) Strawbridge","year":"2023","unstructured":"20-) Strawbridge R, Javed RR, Cave J, Jauhar S, Young AH. The effects of reserpine on depression: A systematic review. J Psychopharmacol 2023; 37(3): 248-60.","journal-title":"J Psychopharmacol"},{"key":"ref20","unstructured":"21-) Sridevi D, Shankar C, Prakash P, Park JH, Thamaraiselvi K. Inhibitory effects of reserpine against efflux pump activity of antibiotic resistance bacteria. Chem Biol Lett 2017; 4(2): 69-72."},{"issue":"5","key":"ref21","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.3390\/ijerph120505177","article-title":"Resistance of Stenotrophomonas maltophilia to fluoroquinolones: Prevalence in a university hospital and possible mechanisms","volume":"12","author":"22-) Jia","year":"2015","unstructured":"22-) Jia W, Wang J, Xu H, Li G. Resistance of Stenotrophomonas maltophilia to fluoroquinolones: Prevalence in a university hospital and possible mechanisms. Int j Environ Res Public Health 2015; 12(5): 5177-95.","journal-title":"Int j Environ Res Public Health"},{"issue":"6","key":"ref22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1055\/s-2000-8661","article-title":"Leishmanicidal, antiplasmodial and cytotoxic activity of indole alkaloids from corynanthe pachyceras","volume":"66","author":"23-) St\u00e6rk","year":"2000","unstructured":"23-) St\u00e6rk D, Lemmich E, Christensen J, Kharazmi A, Olsen CE, Jaroszewski JW. Leishmanicidal, antiplasmodial and cytotoxic activity of indole alkaloids from corynanthe pachyceras. Planta Medica 2000; 66(6): 531-6.","journal-title":"Planta Medica"},{"issue":"11","key":"ref23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3390\/toxins12110713","article-title":"Biological activity of berberine-a summary update","volume":"12","author":"24-) Och","year":"2020","unstructured":"24-) Och A, Podg\u00f3rski R, Nowak R. Biological activity of berberine-a summary update. Toxins 2020; 12(11): 713.","journal-title":"Toxins"},{"key":"ref24","unstructured":"25-) Ahuja A, Purohit SK, Yadav JS, Netra PR. Cutaneous leishmaniasis in domestic dogs. Indian J Public Health 1993; 37: 29-31."},{"issue":"2","key":"ref25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.25258\/ijpqa.11.2.8","article-title":"Antileishmanial effect of berberine and extracts of Berberis vulgaris on the growth of leishmanial species","volume":"11","author":"26-) Hassan HF","year":"2020","unstructured":"26-) Hassan HF, Najim ZK. Antileishmanial effect of berberine and extracts of Berberis vulgaris on the growth of leishmanial species. Int J Pharm Qual Assur 2020; 11(2): 237-41.","journal-title":"Int J Pharm Qual Assur"},{"issue":"9","key":"ref26","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.3390\/molecules15096476","article-title":"and their evaluation as antiparasitic compounds","volume":"15","author":"27-) Ropivia","year":"2010","unstructured":"27-) Ropivia J, Derbr\u00e9 S, Rouger C, Pagniez F, Le Pape P, Richomme P. Isoquinolines from the roots of Thalictrum flavum L. and their evaluation as antiparasitic compounds. Molecules 2010; 15(9): 6476-84.","journal-title":"Molecules"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28-) Mahmoudvand H, Sharififar F, Sharifi I, Ezatpour B, Harandi MF, Makki MS, et al. In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, berberine against different Leishmania species. Iran J Parasitol 2014; 9(1): 28.","DOI":"10.1155\/2014\/602436"},{"issue":"1","key":"ref28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00436-018-6157-3","article-title":"Berberine chloride mediates its antileishmanial activity by inhibiting Leishmania mitochondria","volume":"118","author":"29-) De Sarkar","year":"2019","unstructured":"29-) De Sarkar S, Sarkar D, Sarkar A, Dighal A, Staniek K, Gille L, et al. Berberine chloride mediates its antileishmanial activity by inhibiting Leishmania mitochondria. Parasitol Res 2019; 118(1): 335-45.","journal-title":"Parasitol Res"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30-) Alamzeb M, Ali S, Rashid M, Khan B, Ihsanullah A. Antileishmanial potential of berberine alkaloids from berberis glaucocarpa roots: Molecular docking suggests relevant leishmania protein targets. Nat Prod Commun 2021; 16(9).","DOI":"10.1177\/1934578X211031148"},{"issue":"4","key":"ref30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jac\/dkac007","article-title":"Effect of topical berberine in murine cutaneous leishmaniasis lesions","volume":"77","author":"31-) Calvo","year":"2022","unstructured":"31-) Calvo A, Moreno E, Aldalur I, Sanmart\u00edn C, Larrea E, Gonz\u00e1lez-Pe\u00f1as E, et al. Effect of topical berberine in murine cutaneous leishmaniasis lesions. J Antimicrob Chem 2022; 77(4): 1072-81.","journal-title":"J Antimicrob Chem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.scib.2020.12.035","article-title":"Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p","volume":"66","author":"32-) Tong","year":"2021","unstructured":"32-) Tong Y, Zhang J, Sun N, Wang X-M, Wei Q, Zhang Y, et al. Berberine reverses multidrug resistance in Candida albicans by hijacking the drug efflux pump Mdr1p. Sci Bull 2021; 66: 1895-905.","journal-title":"Sci Bull"},{"key":"ref32","unstructured":"33-) Li Y, Ge X. Role of berberine as a potential efflux pump \u0131nhibitor against MdfA from Escherichia coli: In vitro and in silico studies. Microbiol Spectr 2023; 11(2): e0332422."},{"issue":"3","key":"ref33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/pathogens13030197","article-title":"Types and mechanisms of efflux pump systems and the potential of efflux pump inhibitors in the restoration of antimicrobial susceptibility, with a special reference to Acinetobacter baumannii","volume":"13","author":"34-) Zack","year":"2024","unstructured":"34-) Zack KM, Sorenson T, Joshi SG. Types and mechanisms of efflux pump systems and the potential of efflux pump inhibitors in the restoration of antimicrobial susceptibility, with a special reference to Acinetobacter baumannii. Pathogens 2024; 13(3): 197.","journal-title":"Pathogens"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1126\/science.3544220","article-title":"Reversal of chloroquine resistance in Plasmodium falciparum by verapamil","volume":"235","author":"35-) Martin","year":"1987","unstructured":"35-) Martin SK, Oduola AM, Milhous WK. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science 1987; 235: 899-901.","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exppara.2006.02.015","article-title":"Leishmania donovani: Effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate","volume":"114","author":"36-) Valiathan","year":"2006","unstructured":"36-) Valiathan R, Dubey ML, Mahajan RC, Malla N. Leishmania donovani: Effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Indian clinical isolates to sodium stibogluconate. Exp Parasitol 2006; 114: 103-8.","journal-title":"Exp Parasitol"},{"issue":"3","key":"ref36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00436-011-2599-6","article-title":"The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate","volume":"110","author":"37-) Shokri","year":"2012","unstructured":"37-) Shokri A, Sharifi I, Khamesipour A, Nakhaee N, Fasihi Harandi M, Nosratabadi J, et al. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate. Parasitol Res 2012; 110(3): 1113-7.","journal-title":"Parasitol Res"},{"issue":"3","key":"ref37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5578\/mb.69702","article-title":"T\u00fcrkiye'de kutan\u00f6z ley\u015fmanyazis etkeni Leishmania tropica'da antimon diren\u00e7 mekanizmas\u0131n\u0131n belirlenmesi","volume":"54","author":"38-) \u00d6zbilgin","year":"2020","unstructured":"38-) \u00d6zbilgin A, Zeyrek FY, G\u00fcray MZ, \u00c7ulha G, Akyar I, Harman M ve ark. T\u00fcrkiye'de kutan\u00f6z ley\u015fmanyazis etkeni Leishmania tropica'da antimon diren\u00e7 mekanizmas\u0131n\u0131n belirlenmesi. Mikrobiyol Bul 2020; 54(3): 444-62.","journal-title":"Mikrobiyol Bul"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"115049","DOI":"10.1016\/j.ejmech.2022.115049","article-title":"Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition","volume":"247","author":"39-) Istanbullu","year":"2023","unstructured":"39-) Istanbullu H, Bayraktar G, Karakaya G, Akbaba H, Perk NE, Cavus I, et al. Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition. Eur J Med Chem 2023; 247: 115049.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"ref39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5578\/mb.202498184","article-title":"Hibrit g\u00fcm\u00fc\u015f nanopar\u00e7ac\u0131k komplekslerinin sitotoksik ve antilay\u015fmanyal aktivitesinin ara\u015ft\u0131r\u0131lmas\u0131: Leishmania t\u00fcrlerine kar\u015f\u0131 potansiyel ila\u00e7 adaylar\u0131","volume":"58","author":"40-) \u00d6zel","year":"2024","unstructured":"40-) \u00d6zel Y, \u00c7avu\u015f \u0130, Y\u0131lmaz U, Tokay F, Ba\u011fdat S, \u00d6zbilgin A ve ark. Hibrit g\u00fcm\u00fc\u015f nanopar\u00e7ac\u0131k komplekslerinin sitotoksik ve antilay\u015fmanyal aktivitesinin ara\u015ft\u0131r\u0131lmas\u0131: Leishmania t\u00fcrlerine kar\u015f\u0131 potansiyel ila\u00e7 adaylar\u0131. Mikrobiyol Bul 2024; 58(2): 182-95.","journal-title":"Mikrobiyol Bul"}],"container-title":["Thoracic Research and Practice"],"original-title":[],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T13:50:40Z","timestamp":1736949040000},"score":1,"resource":{"primary":{"URL":"https:\/\/thoracrespract.org\/articles\/doi\/ThoracResPract.2024.23076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,7]]}},"URL":"https:\/\/doi.org\/10.4274\/thoracrespract.2024.23076","relation":{},"ISSN":["2979-9139"],"issn-type":[{"value":"2979-9139","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]}}}